Sign in to follow
Search Results

0 results for 'Boehringer Ingelheim'

You can use to get even better search results
February 27, 2019 | The American Lawyer

Revenue, Partner Profits Hit New Highs at Paul Hastings

Chairman Seth Zachary outlined a strategy that's simple, at least on its face: Win more work, and more complex work.
4 minute read
February 14, 2019 | Litigation Daily

Daily Dicta: Wilmer, Latham Lawyers Swatted in Red-Hot Discovery Fight over World's Best-Selling Drug

A fed-up magistrate judge in Delaware ordered pharma giant AbbVie to turn over requested discovery materials to Boehringer Ingelheim in a patent fight over Humira, the world's best-selling drug.
6 minute read
February 11, 2019 | Delaware Business Court Insider

AbbVie Ordered to Quickly Produce Docs in Humira Infringement Suit

The Feb. 8 ruling, from U.S. Magistrate Judge Richard A. Lloret, came in response to Boehringer's second set of production requests pertaining to its "unclean hands" defense in Abbvie's infringement suit, which accuses the German drugmaker of trying to illegally capitalize on Humira's clinical success.
4 minute read
December 20, 2018 | Litigation Daily

Litigators of the Week for 2018, Take a Bow

From challenging efforts to un-do the Deferred Action for Childhood Arrivals program to prosecuting Bill Cosby to rebuffing DOJ's bid to block the merger of AT&T and Time Warner, here's the full list of our Litigators of the Week this year.
15 minute read
October 19, 2018 | Connecticut Law Tribune

$1.25M Verdict Returned Against Boehringer Ingelheim Over Pradaxa Blood Thinner

A federal jury in West Virginia found Boehringer Ingelheim Pharmaceuticals Inc. liable for the death of an 84-year-old woman who took the blood thinner drug Pradaxa. The company plans to appeal.
4 minute read
October 18, 2018 | Pro Mid Market

Who Got the Work: A Whopper of a Filing, Plus Trial Victories and Deals

Midsize firms getting big-time client work.
2 minute read
October 10, 2018 | Law.com

Critical Mass: Ominous Order for Opioid Defendants

Also this week: A hard to swallow LaCroix class action, and Feds probing asbestos trust.
5 minute read
October 08, 2018 | Connecticut Law Tribune

Covington, Shipman & Goodwin Prevail in Another Defense of Pradaxa

For the third time this year, Connecticut-based drugmaker Boehringer Ingelheim has prevailed in a trial related to the safety of blood thinner Pradaxa.
3 minute read
October 05, 2018 | Law.com

Skilled in the Art: What Do Jurors Know About Damages? | Another Bad Diagnosis on 101 | Lyft Wants Out of SDNY

Time Warner says the $140 million verdict it got hit with last year was unduly influenced by admission of a previous verdict against a different party. Federal Circuit judges seemed to agree there should be some limits on such evidence.
9 minute read
October 02, 2018 | Corporate Counsel

Ascena Retail Bags New GC From Boehringer Ingelheim

Ascena, the retail group behind brands such as Ann Taylor, Justice and Dress Barn, has appointed a new top lawyer several months after its former GC moved to U.S. Steel.
2 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now